Richard Keefe, PhD, is Professor of Psychiatry and Behavioral Sciences at Duke University Medical Center in Durham, North Carolina. He received his BA from Princeton University and his PhD in clinical psychology from New York University. His research is primarily devoted to understanding cognitive dysfunction and its treatment in patients with schizophrenia and related disorders, including those at high risk for schizophrenia. Dr Keefe has had a leadership role in several large National Institute of Mental Health studies including the CATIE, MATRICS, TURNS, and TENETS projects. He has authored more than 160 peer-reviewed scientific papers and two books. He serves on the editorial boards of several journals, including Schizophrenia Research, Schizophrenia Bulletin, and Innovations in Clinical Neuroscience, and is Associate Editor of Psychological Medicine. He is President of the International Society for CNS Clinical Trials and Methodology for 2012–2014. He is the Founder and CEO of NeuroCog Trials, Inc. He is a Co-Principal Investigator and Director of the Neurocognitive Core for the Translational and Clinical Research Neuroscience project at the Institute of Mental Health in Singapore.

• Symptom rating scales in schizophrenia.- Depression and suicidality.- Cognition.- Functional outcomes assessment scales.- Quality of life measurements in a person with schizophrenia.- Antipsychotic side-effect rating scales in schizophrenia.- Assessment scales for insight.- Assessing adherence to antipsychotic medications.- Clinical assessment scales in substance use disorders.- Medical comorbidities.

Richard Keefe, PhD, is Professor of Psychiatry and Behavioral Sciences at Duke University Medical Center in Durham, North Carolina. He received his BA from Princeton University and his PhD in clinical psychology from New York University. His research is primarily devoted to understanding cognitive dysfunction and its treatment in patients with schizophrenia and related disorders, including those at high risk for schizophrenia. Dr Keefe has had a leadership role in several large National Institute of Mental Health studies including the CATIE, MATRICS, TURNS, and TENETS projects. He has authored more than 160 peer-reviewed scientific papers and two books. He serves on the editorial boards of several journals, including Schizophrenia Research, Schizophrenia Bulletin, and Innovations in Clinical Neuroscience, and is Associate Editor of Psychological Medicine. He is President of the International Society for CNS Clinical Trials and Methodology for 2012–2014. He is the Founder and CEO of NeuroCog Trials, Inc. He is a Co-Principal Investigator and Director of the Neurocognitive Core for the Translational and Clinical Research Neuroscience project at the Institute of Mental Health in Singapore.

• Symptom rating scales in schizophrenia.- Depression and suicidality.- Cognition.- Functional outcomes assessment scales.- Quality of life measurements in a person with schizophrenia.- Antipsychotic side-effect rating scales in schizophrenia.- Assessment scales for insight.- Assessing adherence to antipsychotic medications.- Clinical assessment scales in substance use disorders.- Medical comorbidities.

Richard Keefe, PhD, is Professor of Psychiatry and Behavioral Sciences at Duke University Medical Center in Durham, North Carolina. He received his BA from Princeton University and his PhD in clinical psychology from New York University. His research is primarily devoted to understanding cognitive dysfunction and its treatment in patients with schizophrenia and related disorders, including those at high risk for schizophrenia. Dr Keefe has had a leadership role in several large National Institute of Mental Health studies including the CATIE, MATRICS, TURNS, and TENETS projects. He has authored more than 160 peer-reviewed scientific papers and two books. He serves on the editorial boards of several journals, including Schizophrenia Research, Schizophrenia Bulletin, and Innovations in Clinical Neuroscience, and is Associate Editor of Psychological Medicine. He is President of the International Society for CNS Clinical Trials and Methodology for 2012–2014. He is the Founder and CEO of NeuroCog Trials, Inc. He is a Co-Principal Investigator and Director of the Neurocognitive Core for the Translational and Clinical Research Neuroscience project at the Institute of Mental Health in Singapore.

• Symptom rating scales in schizophrenia.- Depression and suicidality.- Cognition.- Functional outcomes assessment scales.- Quality of life measurements in a person with schizophrenia.- Antipsychotic side-effect rating scales in schizophrenia.- Assessment scales for insight.- Assessing adherence to antipsychotic medications.- Clinical assessment scales in substance use disorders.- Medical comorbidities.